文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

非转移性前列腺癌根治性放疗患者分期MRI使用中的差异

Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy.
PubMed 文献 · Adv Radiat Oncol · 2016-07-25

本研究基于2005至2013年接受放疗的705例非转移性前列腺癌患者机构数据库,分析治疗前诊断性前列腺mpMRI的使用与临床及人口学特征的关系。单因素分析显示除其他种族外所有人口学变量均与MRI使用显著相关;多因素分析按D'Amico风险组分層后,年龄在所有风险组仍显著,黑人与白人种族差异及非私人保险与私人保险差异在低风险组持续存在。结论认为老年患者及低风险组黑人、非私人保险患者接受分期MRI的可能性更低。

要点

  • 所有风险组中年龄较大者接受分期前列腺MRI的可能性更低。
  • 低风险组中黑人较白人及非私人保险较私人保险者MRI使用率更低。
  • 临床T3期是高危组中与MRI使用相关的临床特征。

核心结论

  • 在该城市学术中心队列中,所有风险组的老年患者以及低风险组的黑人或非私人保险患者接受分期前列腺MRI的可能性更低。

研究设计与样本

  • 回顾性机构数据库研究,纳入2005至2013年接受放疗的705例非转移性前列腺癌患者,比较治疗前是否接受诊断性前列腺mpMRI。
  • 采用单因素和多因素logistic回归评估临床与人口学特征与MRI使用的关系,多因素分析按D'Amico风险组分层。

主要发现

  • 单因素分析中除其他种族类别外所有人口学变量均与MRI使用显著相关(均P < .05),包括年龄(OR 0.92)、黑人种族(OR 0.51)、贫困(OR 0.53)、距放疗机构更近(OR 1.79)、非私人主要保险(OR 0.57),临床T3期(OR 3.37)是唯一临床特征。
  • 多因素分析按D'Amico风险组分层后,年龄在所有风险组仍显著。
  • 低风险组中黑人较白人种族(OR 0.21;95%CI 0.08-0.55)及非私人较私人保险类型(OR 0.37;95%CI 0.16-0.86)的差异持续存在。
  • 高危组中临床T3期仍与MRI使用相关。
  • 总体队列及按风险组的MRI使用百分比:总体白人80%(343/427)、黑人68%(156/231)、其他85%(40/47);低风险86%、56%、63%;中风险79%、72%、95%;高风险72%、72%、100%。

临床怎么用

  • 在根治性放疗前分期中,应关注老年患者及低风险组黑人、非私人保险患者可能较少接受前列腺mpMRI。
  • 需进一步研究以确保所有人口学群体公平使用分期MRI。

局限性

  • 本研究为单中心城市学术中心队列,结果外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: There is growing evidence supporting incorporating multiparametric (mp) magnetic resonance imaging (MRI) scans into risk stratification, active surveillance, and treatment paradigms for prostate cancer. The purpose of our study was to determine whether demographic disparities exist in staging MRI utilization for prostate cancer patients. METHODS AND MATERIALS: An institutional database of 705 nonmetastatic prostate cancer patients treated with radiation therapy from 2005 through 2013 was used to identify patients undergoing versus not undergoing pretreatment diagnostic prostate mpMRI. Uni- and multivariable logistic regression evaluated the relationship of clinical and demographic characteristics with MRI utilization. RESULTS: All demographic variables assessed, except the other race category, were significantly associated with MRI utilization (all P < .05), including age (odds ratio [OR], 0.92), black race (OR, 0.51), poverty (OR, 0.53), closer distance to radiation facility (OR, 1.79), and nonprivate primary insurance (OR, 0.57) on univariable analysis, while clinical stage T3 (OR, 3.37) was the only clinical characteristic. On multivariable analysis stratified by D'Amico risk group, age remained significant across all risk groups, whereas the black versus white racial (OR, 0.21; 95% confidence interval, 0.08-0.55) and nonprivate versus private insurance type (OR, 0.37; 95% confidence interval, 0.16-0.86) disparities persisted in the low-risk group. Clinical stage T3 remained associated in the high-risk group. For race specifically, the percentages of whites, blacks, and others undergoing MRI in the overall cohort and by risk group were, respectively: overall, 80% (343/427), 68% (156/231), and 85% (40/47); low risk, 86%, 56%, and 63%; intermediate risk, 79%, 72%, and 95%; and high risk, 72%, 72%, and 100%. CONCLUSIONS: In this urban, academic center cohort, older patients across all risk groups and black or nonprivate insurance patients in the low risk group were less likely to undergo staging prostate MRI scans. Further research should investigate these differences to ensure equitable utilization across all demographic groups considering the burden of prostate cancer disparities.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ajayi A, Hwang WT, Vapiwala N, et al. Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy. Adv Radiat Oncol. 2016. PMID: 28740904. doi:10.1016/j.adro.2016.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。